Connect with us


DNANudge a Rapid Covid-Testing Firm Raised $60 Million From Ventura Capital



As the fight against Covid-19 edges on with the rapidly spreading Delta variant spreads globally, there is an increased interest from investors in Covid-19 related technology. This include diagnostics and vaccines. In the U.S., DNANudge Ltd., a maker of rapid Covid tests that were adapted on the fly from a consumer dietary-guidance technology, has received $60 million in funding led by Ventura Capital in a bid to ramp up production and expand diagnostic applications.

DNANudge will use the funding, which includes participation by Bank Julius Baer, to make more cartridges for its portable devices, which can diagnose Covid in about an hour, founder Christofer Toumazou said in an interview. The company is also making cartridges for cancer testing and consumer skin-care products.

Continue Reading


Sign up for our Newsletter

Enter your email and stay on top of things,